Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
20 Oktoba 2026, 08:12:03
Haematuria (blood in urine)
Assessment
History: duration, urinary symptoms, trauma or instrumentation, UTIs or schistosomiasis exposure, anticoagulants or herbal medicines, cancer risk (over 40 years, smoking, occupation).
Examination: vital signs (anaemia, shock), flank tenderness, bladder distension or masses, genitalia.
Tests: urinalysis and microscopy (RBC morphology), urine culture, CBC, coagulation profile; ultrasound KUB first, X-ray KUB, CT/IV urography when indicated; cystoscopy for persistent unexplained gross haematuria, especially over 40 years.
Management by cause
Cause | Management |
UTI | Antibiotics by local sensitivity (e.g. nitrofurantoin, ciprofloxacin, ceftriaxone), fluids, analgesia |
Schistosomiasis | Praziquantel 40 mg/kg single dose |
Stones | NSAID analgesia, hydration, referral for lithotripsy or surgery if obstructed or infected |
Trauma | Bed rest, analgesia, catheter if retention, surgery if severe |
Suspected cancer | Urgent referral for cystoscopy and biopsy |
Glomerular disease | Nephrology referral |
Coagulopathy | Correct it; transfuse if severe; haematology advice |
Obstruction | Relieve by catheter or surgery; monitor kidney function |
Supportive care: hydration, monitor vital signs and Hb, transfuse only if indicated, paracetamol or NSAIDs.
Refer: persistent unexplained haematuria, clot retention, suspected malignancy, severe anaemia or instability.
Imeandikwa:
20 Oktoba 2026, 08:09:44
Rejea za mada hii:
Ministry of Health, United Republic of Tanzania. Standard Treatment Guidelines and National Essential Medicines List for Tanzania Mainland (STG & NEMLIT). 7th ed. Dodoma: Ministry of Health; 2026. Chapter 21, Kidney and Urological Disorders: section 21.11.1 Hematuria (Tables 21.31–21.32), pp. 558–559.
